LEADER 02315nam  2200505Ia 450 
001 9910811612103321
005 20230422045220.0
035   $a(CKB)1000000000450571
035   $a(EBL)3377440
035   $a(SSID)ssj0000250882
035   $a(PQKBManifestationID)11238711
035   $a(PQKBTitleCode)TC0000250882
035   $a(PQKBWorkID)10247784
035   $a(PQKB)10734214
035   $a(MiAaPQ)EBC3377440
035   $a(Au-PeEL)EBL3377440
035   $a(CaPaEBR)ebr10071468
035   $a(OCoLC)923270349
035   $a(EXLCZ)991000000000450571
100   $a20050324d2000      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aState programs can reduce tobacco use$b[electronic resource] /$fNational Cancer Policy Board, Institute of Medicine, National Research Council
210   $aWashington, D.C. $cNational Cancer Policy Board$dc2000
215   $a1 online resource (17 p.)
300   $a"This study was supported through funding provided by...the Centers for Disease Control and Prevention; the American Cancer Society; Amgen, Inc.; Abbott Laboratories and Hoechst Marion Roussel, Inc.
311   $a0-309-57581-8 
320   $aIncludes bibliographical references.
327   $a""State Programs Can Reduce Tobacco Use""; ""WHAT IS THE EVIDENCE THAT STATE PROGRAMS MAKE A DIFFERENCE?""; ""COUNTERADVERTISING AND EDUCATION""; ""ESTABLISHING SMOKE-FREE WORKPLACES AND PUBLIC SPACES""; ""INCREASING PRICES THROUGH TAXATION""; ""SUPPORTING TREATMENT PROGRAMS FOR TOBACCO DEPENDENCE""; ""ENFORCING YOUTH ACCESS RESTRICTIONS44""; ""MONITORING PERFORMANCE AND EVALUATING PROGRAMS""; ""CONCLUSIONS""; ""NOTES""; ""NATIONAL CANCER POLICY BOARD""; ""BOARD ON HEALTH PROMOTION AND DISEASE PREVENTION""; ""STAFF""; ""INDEPENDENT REPORT REVIEWERS""
606   $aTobacco use$zUnited States$xPrevention
606   $aSubstance abuse$zUnited States$xPrevention
615  0$aTobacco use$xPrevention.
615  0$aSubstance abuse$xPrevention.
676   $a616.865
712 02$aNational Cancer Policy Board (U.S.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910811612103321
996   $aState programs can reduce tobacco use$94031762
997   $aUNINA